Inactive Instrument

Other languages Chinook Therapeutics, Inc.

Equities

KDNY

US16961L1061

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

EN DIRECTO DESDE LOS MERCADOS: Philips, Renault, Novartis, Pernod Ricard, Valneva, SoftBank, Country Garden, Shell...	23-08-14
Bolsa de Madrid: La renta variable sube, pero no los tipos	23-08-14
Aktien Schweiz Vorbörse: SMI im Rückwärtsgang erwartet	23-08-14
Principales informations avant-Bourse	23-08-14
En direct des marchés : Renault, Pernod Ricard, Valneva, SoftBank, Country Garden, Shell...	23-08-14
Les actions plafonnent, mais pas les taux	23-08-14
Chinook Therapeutics, Inc. Announces Board Cessations	23-08-11
Novartis completa l'acquisizione della statunitense Chinook	23-08-11
Novartis Says it Completed Chinook Therapeutics Acquisition	23-08-11
Novartis Completes Acquisition of Chinook Therapeutics for Up to $3.5 Billion	23-08-11
Novartis finalise l'acquisition de l'américain Chinook Therapeutics	23-08-11
Novartis : finalise l'acquisition de Chinook pour 3,5 Mds$	23-08-11
Novartis schliesst Akquisition von Chinook Therapeutics ab	23-08-11
Novartis AG completed the acquisition of Chinook Therapeutics, Inc. from a group of shareholders.	23-08-10
Chinook Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
Chinook Therapeutics Says First Patient Enrolled in Phase 3 Trial of Zigakibart to Treat IgA Nephropathy	23-07-28
Chinook Therapeutics, Inc. Announces the First Patient Enrolled in its Phase 3 Second Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy	23-07-28
HBM Healthcare startet mit Verlust ins Geschäftsjahr 2023/24	23-07-21
Prévisions Novartis: 13,2 milliards de dollars de revenus au 2e trimestre	23-07-17
Ausblick Novartis: Q2-Umsatz von 13,2 Milliarden US-Dollar erwartet	23-07-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Chinook Therapeutics, Inc.

Equities

KDNY

US16961L1061

Other languages

Filters